Menu

Filtros : "Emirados Árabes Unidos" "ALBUQUERQUE, SÉRGIO DE" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives (2020)

    Lima, Camilo Henrique da Silva; Soares, Júlio César de Araujo Vanelis; Ribeiro, Joana Lucius de Sousa; Muri, Estela Maris Freitas; Albuquerque, Sérgio de ; Dias, Luiza Rosaria Sousa

    Source: Letters in Drug Design & Discovery. Unidade: FCFRP

    Subjects: TRYPANOSOMA CRUZI, TRIPANOSSOMICIDAS, ENSAIO CLÍNICO, CITOTOXICIDADE IMUNOLÓGICA, ANTIPARASITÁRIOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LIMA, Camilo Henrique da Silva et al. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives. Letters in Drug Design & Discovery, v. 17, n. 2, p. 184-191, 2020Tradução . . Disponível em: https://doi.org/10.2174/1570180816666190305141733. Acesso em: 20 maio 2024.

    • APA

      Lima, C. H. da S., Soares, J. C. de A. V., Ribeiro, J. L. de S., Muri, E. M. F., Albuquerque, S. de, & Dias, L. R. S. (2020). Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives. Letters in Drug Design & Discovery, 17( 2), 184-191. doi:10.2174/1570180816666190305141733

    • NLM

      Lima CH da S, Soares JC de AV, Ribeiro JL de S, Muri EMF, Albuquerque S de, Dias LRS. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives [Internet]. Letters in Drug Design & Discovery. 2020 ; 17( 2): 184-191.[citado 2024 maio 20 ] Available from: https://doi.org/10.2174/1570180816666190305141733

    • Vancouver

      Lima CH da S, Soares JC de AV, Ribeiro JL de S, Muri EMF, Albuquerque S de, Dias LRS. Anti-Trypanosoma cruzi activity and molecular docking studies of 1Hpyrazolo[ 3, 4-b]pyridine derivatives [Internet]. Letters in Drug Design & Discovery. 2020 ; 17( 2): 184-191.[citado 2024 maio 20 ] Available from: https://doi.org/10.2174/1570180816666190305141733

  • Artigo de periodico

    Discovery of 2-aminopyridine Derivatives with Antichagasic and Antileishmanial Activity Using Phenotypic Assays (2020)

    Tezuka, Daiane Yukie; Albuquerque, Sérgio de ; Montanari, Carlos Alberto ; Leitão, Andrei

    Source: Letters in Drug Design and Discovery. Unidades: IQSC, BIOENGENHARIA, FCFRP

    Assunto: LEISHMANIA

    PrivadoAcesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TEZUKA, Daiane Yukie et al. Discovery of 2-aminopyridine Derivatives with Antichagasic and Antileishmanial Activity Using Phenotypic Assays. Letters in Drug Design and Discovery, v. 17, n. 7, p. 867-872, 2020Tradução . . Disponível em: https://doi.org/10.2174/1570180816666191204105232. Acesso em: 20 maio 2024.

    • APA

      Tezuka, D. Y., Albuquerque, S. de, Montanari, C. A., & Leitão, A. (2020). Discovery of 2-aminopyridine Derivatives with Antichagasic and Antileishmanial Activity Using Phenotypic Assays. Letters in Drug Design and Discovery, 17( 7), 867-872. doi:10.2174/1570180816666191204105232

    • NLM

      Tezuka DY, Albuquerque S de, Montanari CA, Leitão A. Discovery of 2-aminopyridine Derivatives with Antichagasic and Antileishmanial Activity Using Phenotypic Assays [Internet]. Letters in Drug Design and Discovery. 2020 ; 17( 7): 867-872.[citado 2024 maio 20 ] Available from: https://doi.org/10.2174/1570180816666191204105232

    • Vancouver

      Tezuka DY, Albuquerque S de, Montanari CA, Leitão A. Discovery of 2-aminopyridine Derivatives with Antichagasic and Antileishmanial Activity Using Phenotypic Assays [Internet]. Letters in Drug Design and Discovery. 2020 ; 17( 7): 867-872.[citado 2024 maio 20 ] Available from: https://doi.org/10.2174/1570180816666191204105232
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024